Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis - Wikidata - awgldk - TriplyDB

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

http://www.wikidata.org/entity/Q30833019

about

Quantitative neuropathology: an update on automated methodologies and implications for large scale cohorts.Narrative Organization Deficit in Lewy Body Disorders Is Related to Alzheimer Pathology.Parkinson's Disease: From Pathogenesis to Pharmacogenomics Impact of multiple pathologies on the threshold for clinically overt dementia.Apolipoprotein E and Alzheimer's disease: the influence of apolipoprotein E on amyloid-β and other amyloidogenic proteins.Interactions of pathological proteins in neurodegenerative diseases.Does Vitamin C Influence Neurodegenerative Diseases and Psychiatric Disorders?Clinicopathologic discrepancies in a population-based incidence study of parkinsonism in olmsted county: 1991-2010.Current concepts and controversies in the pathogenesis of Parkinson's disease dementia and Dementia with Lewy Bodies.Lessons learned about [F-18]-AV-1451 off-target binding from an autopsy-confirmed Parkinson's case Emerging Diagnostic and Therapeutic Strategies for Tauopathies.Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls.Mortality in dementia with Lewy bodies compared with Alzheimer's dementia: a retrospective naturalistic cohort study.MicroRNA expression patterns in human anterior cingulate and motor cortex: A study of dementia with Lewy bodies cases and controls.Spread of aggregates after olfactory bulb injection of α-synuclein fibrils is associated with early neuronal loss and is reduced long term.APOE, thought disorder, and SPARE-AD predict cognitive decline in established Parkinson's disease.Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry.Critical appraisal of pathology transmission in the α-synuclein fibril model of Lewy body disorders.The limbic and neocortical contribution of α-synuclein, tau, and amyloid β to disease duration in dementia with Lewy bodies.Small-molecule PET Tracers for Imaging Proteinopathies.Functional connectivity in dementia with Lewy bodies: A within- and between-network analysis.The multi-morbid old brain.Accuracy of Clinical Diagnosis of Dementia with Lewy Bodies versus Neuropathology.Dementia with Lewy bodies and Parkinson's disease-dementia: current concepts and controversies.Improving the identification of dementia with Lewy bodies in the context of an Alzheimer's-type dementia.Neuroimaging in Dementia.Office-Based Screening for Dementia in Parkinson Disease: The Montreal Parkinson Risk of Dementia Scale in 4 Longitudinal Cohorts.Cerebrospinal fluid α-synuclein contributes to the differential diagnosis of Alzheimer's disease.Cerebrovascular Lesions in Mixed Neurodegenerative Dementia: A Neuropathological and Magnetic Resonance Study.CSF tau and β-amyloid predict cerebral synucleinopathy in autopsied Lewy body disorders.α-Synuclein fibril-induced paradoxical structural and functional defects in hippocampal neurons.Are dementia with Lewy bodies and Parkinson's disease dementia the same disease?Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET.Can neuroimaging predict dementia in Parkinson's disease?Relative survival in patients with dementia with Lewy bodies and Parkinson's disease dementia Protein Co-Aggregation Related to Amyloids: Methods of Investigation, Diversity, and Classification

P2860

Q33734079-B5B6DCDF-E4A0-4446-A8C7-A30AFAA54C7E Q37629836-7C1D0F12-DC3E-4492-9B21-AAFA4A70D810 Q37729129-61F9C816-4626-4753-ABD6-5603A666AD27 Q38794960-092CFAB4-7971-4319-8766-62CE1C8784AE Q39155261-5F3AFC28-008E-418F-A9A3-92EEA74ED2CD Q39236779-15A3A295-C9B2-4BE8-8142-EFF88D0E356C Q39400501-D50AB41C-5AF6-4B0F-B9D5-8555A41DA24D Q40069625-68C14F46-FEC7-42CD-B0C8-4436200B7753 Q41589030-59AE1881-3012-4D09-8952-181A02920104 Q42672461-255898A8-7018-4425-8415-B99883682AAC Q45870549-E2C86CA7-E1FF-4FC9-93A3-C414C9AAF9A3 Q46012657-48710822-A90A-4295-91FE-55B20A7B2B66 Q47119828-BF5B8BCA-86D0-4FF0-9657-165CFD02379B Q47214829-0A7725DC-5EB6-4D58-9EE8-6E368103E41B Q47361450-2F534F15-6862-4974-AEA1-E3133953B2E6 Q47571451-65182D0C-C644-4677-9DAC-7BCD9181DD4C Q47587631-1C6F15A6-47A6-4077-AC1F-5491D5D8D844 Q47619917-67F16DEE-B068-4A93-95DF-54E806E47958 Q47666324-A64FF585-1384-488B-83E6-4F68B069DBD4 Q47926474-714893AD-3542-4DF6-87FC-1F4105D0B793 Q47940917-056E4515-A619-48AB-84CC-18104A482D18 Q48137063-4BBFCB10-D96C-4031-8721-A4D92899659B Q48616513-13BE4A18-7DE0-48AC-8CC5-70C6B0F18593 Q49987358-272A95AF-C4CC-4663-A4CD-250D13F9FFF8 Q51766645-634E6803-9250-4804-95A1-07E82861B2B4 Q51800676-CF7EE38B-990B-4BE0-960A-72EB4610C64D Q53396773-09F42524-FC5D-483E-BAC5-DF87358DD9C8 Q53396870-8C521043-BFBA-42E8-9C3E-3D1CF39360E9 Q53504163-EE8D915C-C640-4D10-83EF-CCBE00426440 Q53512229-1CD22363-FFDA-49A5-B11D-88A6ED18E85E Q53827082-8C2D72DD-EA8B-4137-9850-BC91BF418370 Q54982491-B0F5D8C7-2D3A-4046-9A06-6D67A5B1774A Q55709566-7A654326-B18F-45BC-8F15-6898C8E5A3DB Q58696822-0C370645-989C-46B3-9412-0BAC6500BC13 Q58791278-3AF7A24B-15A8-4154-8466-B6FE0C2EB669 Q58800414-E7EAAEBE-23C3-4BDB-B9D2-DD43883FE0F4

P2860

Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis

http://www.wikidata.org/entity/Q30833019

description

2017 nî lūn-bûn

@nan

2017 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Neuropathological and genetic ...... hies: a retrospective analysis

@ast

Neuropathological and genetic ...... hies: a retrospective analysis

@en

type

label

Neuropathological and genetic ...... hies: a retrospective analysis

@ast

Neuropathological and genetic ...... hies: a retrospective analysis

@en

prefLabel

Neuropathological and genetic ...... hies: a retrospective analysis

@ast

Neuropathological and genetic ...... hies: a retrospective analysis

@en

P1433

Q30833019-4D5CE662-95DE-4F04-9700-961DC42EC586

P1476

Q30833019-5213D626-77F3-4B5E-8397-E2DED57FC1B0

P2093

Q30833019-068F4206-B490-41E0-92A0-A659A1884DD0

Q30833019-114B33DB-C90D-4D5C-B6F3-DAF6A650EFE6

Q30833019-1C45963E-903E-45EF-87B8-402CBD6942BF

Q30833019-2E13B9E8-3F91-4172-BC0C-6E5DBA38B032

Q30833019-31B85734-4359-4B72-A894-83EA0990442C

Q30833019-35951A66-BD1A-4AA6-8C74-CB4FBE0DF961

Q30833019-4F4AF3E6-1F1A-489B-A8B0-EA34D1794221

Q30833019-6326C18F-79F9-456C-A72C-B9ACFACA393A

Q30833019-7203D76D-F53C-4C48-908B-AF156761569C

Q30833019-73204ED9-7274-4CD8-AE4D-10E35B4BEF72

P2860

Q30833019-0A6266D0-5AA5-43DA-827D-F11010F314D0

Q30833019-18A6B872-7637-4B98-98FF-BA85E3611951

Q30833019-19B540C7-01E4-4C35-9E96-25D6D673FCE1

Q30833019-1CFC44B0-DFAC-4C4B-BDB9-9E6EBF5A65FF

Q30833019-22FF64C8-8FE4-40C1-8B27-FA33A3DA50FE

Q30833019-2EBCB15A-6D81-4B5D-AEC7-9F3818D4AA3A

Q30833019-39B325C6-FCDD-4D13-A293-96677509CFCC

Q30833019-3CD7668E-769A-4E78-A401-A2F19C3D1244

Q30833019-43090330-7A8C-48F4-9637-E2AE65330BA2

Q30833019-4A7050B2-FB03-4B05-842B-02BCDF2D11CB

P304

Q30833019-32DBC030-2B84-49C8-B370-F9A55DCDC7AA

P31

Q30833019-355007C0-F794-4BC3-A1A5-4E08943FB05F

P356

Q30833019-5621004F-62C4-45B3-9D99-94E3BCD8D0C1

P433

Q30833019-E321A1F6-C3DC-4547-815E-E44FB9295E22

P478

Q30833019-EE207B2A-5CAA-4363-B8CF-3E6075242F3A

P50

Q30833019-66D8AD33-78FF-4623-9724-5DF394BFBA5C

Q30833019-9117293A-4052-463B-A2AF-D906AFDD5438

Q30833019-ECFB361B-F9BA-412B-AABF-71D258DCAB75

P577

Q30833019-AB46C63F-CF79-49F5-AB6C-CC43CAB63A3D

P698

Q30833019-0390ACDD-429D-4FED-B7DF-E392BC6C13C9

P921

Q30833019-2BF88258-19FC-4A05-99C0-FD2A262F5151

P932

Q30833019-694DC48D-A0C0-494E-A7F6-327905A45C61

P356

S1474-4422(16)30291-5

P1433

Lancet Neurology

P1476

Neuropathological and genetic ...... hies: a retrospective analysis

@en

P2093

C Dirk Keene

http://www.w3.org/2001/XMLSchema#string

Cyrus P Zabetian

http://www.w3.org/2001/XMLSchema#string

Daniel Weintraub

http://www.w3.org/2001/XMLSchema#string

David J Irwin

http://www.w3.org/2001/XMLSchema#string

Debby Tsuang

http://www.w3.org/2001/XMLSchema#string

Dora Yearout

http://www.w3.org/2001/XMLSchema#string

Edward B Lee

http://www.w3.org/2001/XMLSchema#string

Gregory A Jicha

http://www.w3.org/2001/XMLSchema#string

Howard I Hurtig

http://www.w3.org/2001/XMLSchema#string

James B Leverenz

http://www.w3.org/2001/XMLSchema#string

P2860

Parkinson's disease dementia: convergence of α-synuclein, tau and amyloid-β pathologies.

Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson's disease

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Distinct α-synuclein strains differentially promote tau inclusions in neurons

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

Neuropathologic substrates of Parkinson disease dementia.

GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology.

GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

Association of cerebrospinal fluid β-amyloid 1-42, T-tau, P-tau181, and α-synuclein levels with clinical features of drug-naive patients with early Parkinson disease.

P304

55-65

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/S1474-4422(16)30291-5

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P50

Walter A. Kukull

John Q. Trojanowski

Murray Grossman

P577

2017-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27979356

http://www.w3.org/2001/XMLSchema#string

P921

P932

5181646

http://www.w3.org/2001/XMLSchema#string